Skip to main content
Top
Published in: Reproductive Health 1/2017

Open Access 01-12-2017 | Research

Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion

Authors: Brandon Howard, ElizaBeth Grubb, Maureen J. Lage, Boxiong Tang

Published in: Reproductive Health | Issue 1/2017

Login to get access

Abstract

Background

Long-acting reversible contraceptives such as intrauterine devices (IUDs) are highly effective in preventing pregnancy, cost effective, and increasing in popularity. It is unclear whether changes in IUD use are associated with changes in rates of irreversible tubal sterilization. In this analysis, we evaluate changes in rates of tubal sterilization, insertion of copper or levonorgestrel (LNG) IUDs, and related complications over time.

Methods

Data were obtained from a retrospective claims database (OptumTM ClinformaticsTM Data Mart) of women aged 15 to 45 years who underwent insertion of copper or LNG IUD or tubal sterilization between 1/1/2006 and 12/31/2011. Outcomes of interest included annual rates of insertion or sterilization and annual rates of potential complications and side effects.

Results

The number of women included in the analysis each year ranged from 1,870,675 to 2,016,916. Between 2006 and 2011, copper IUD insertion claim rates increased from 0.18 to 0.25% and LNG IUD insertion claim rates increased from 0.63 to 1.15%, while sterilization claims decreased from 0.78 to 0.66% (P < 0.0001 for all comparisons). Increases in IUD insertion were apparent in all age groups; decreases in tubal sterilization occurred in women aged 20 to 34 years. The most common side effects and complications were amenorrhea (7.36–11.59%), heavy menstrual bleeding (4.85–15.69%), and pelvic pain (11.12–14.27%). Significant increases in claims of certain complications associated with IUD insertion or sterilization were also observed.

Conclusion

Between 2006 and 2011, a decrease in sterilization rates accompanied an increase in IUD insertion rates, suggesting that increasing numbers of women opted for reversible methods of long-term contraception over permanent sterilization.
Literature
1.
go back to reference D’Arcangues C. Worldwide use of intrauterine devices for contraception. Contraception. 2007;75(6 suppl):S2–7.CrossRefPubMed D’Arcangues C. Worldwide use of intrauterine devices for contraception. Contraception. 2007;75(6 suppl):S2–7.CrossRefPubMed
2.
go back to reference Kaneshiro B, Aeby T. Long-term safety, efficacy, and patient acceptability of the intrauterine copper T-380A contraceptive device. Int J Women’s Health. 2010;2:211–20.CrossRef Kaneshiro B, Aeby T. Long-term safety, efficacy, and patient acceptability of the intrauterine copper T-380A contraceptive device. Int J Women’s Health. 2010;2:211–20.CrossRef
3.
go back to reference Buhling KJ, Zite NB, Lotke P, Black K. Worldwide use of intrauterine contraception: a review. Contraception. 2014;89:162–73.CrossRefPubMed Buhling KJ, Zite NB, Lotke P, Black K. Worldwide use of intrauterine contraception: a review. Contraception. 2014;89:162–73.CrossRefPubMed
4.
go back to reference Branum A, Jones J. Trends in long-acting reversible contraception use among U.S. women aged 15–44. NCHS Data Brief. 2015;188:1–8. Branum A, Jones J. Trends in long-acting reversible contraception use among U.S. women aged 15–44. NCHS Data Brief. 2015;188:1–8.
5.
go back to reference National Center for Chronic Disease Prevention and Health Promotion. U.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. Morb Mortal Wkly Rep. 2013;62:1–46. National Center for Chronic Disease Prevention and Health Promotion. U.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. Morb Mortal Wkly Rep. 2013;62:1–46.
6.
go back to reference Berenson AB, Tan A, Hirth JM, Wilkinson GS. Complications and continuation of intrauterine device use among commercially insured teenagers. Obstet Gynecol. 2013;121:951–8.CrossRefPubMedPubMedCentral Berenson AB, Tan A, Hirth JM, Wilkinson GS. Complications and continuation of intrauterine device use among commercially insured teenagers. Obstet Gynecol. 2013;121:951–8.CrossRefPubMedPubMedCentral
7.
go back to reference Foster DG, Rostovtseva DP, Brindis CD, Biggs MA, Hulett D, Darney PD. Cost savings from the provision of specific methods of contraception in a publicly funded program. Am J Public Health. 2009;99:446–51.CrossRefPubMedPubMedCentral Foster DG, Rostovtseva DP, Brindis CD, Biggs MA, Hulett D, Darney PD. Cost savings from the provision of specific methods of contraception in a publicly funded program. Am J Public Health. 2009;99:446–51.CrossRefPubMedPubMedCentral
8.
go back to reference Trussell J, Henry N, Hassan F, Prezioso A, Law A, Filonenko A. Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception. Contraception. 2013;87:154–61.CrossRefPubMed Trussell J, Henry N, Hassan F, Prezioso A, Law A, Filonenko A. Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception. Contraception. 2013;87:154–61.CrossRefPubMed
9.
go back to reference Trussell J, Hassan F, Lowin J, Law A, Filonenko A. Achieving cost-neutrality with long-acting reversible contraceptive methods. Contraception. 2015;91:49–56.CrossRefPubMed Trussell J, Hassan F, Lowin J, Law A, Filonenko A. Achieving cost-neutrality with long-acting reversible contraceptive methods. Contraception. 2015;91:49–56.CrossRefPubMed
10.
go back to reference Xu X, Macaluso M, Ouyang L, Kulczycki A, Grosse SD. Revival of the intrauterine device: increased insertions among US women with employer-sponsored insurance, 2002–2008. Contraception. 2012;85:155–9.CrossRefPubMed Xu X, Macaluso M, Ouyang L, Kulczycki A, Grosse SD. Revival of the intrauterine device: increased insertions among US women with employer-sponsored insurance, 2002–2008. Contraception. 2012;85:155–9.CrossRefPubMed
11.
go back to reference Whitaker AK, Sisco KM, Tomlinson AN, Dude AM, Martins SL. Use of the intrauterine device among adolescent and young adult women in the United States from 2002 to 2010. J Adolesc Health. 2013;53:401–6.CrossRefPubMed Whitaker AK, Sisco KM, Tomlinson AN, Dude AM, Martins SL. Use of the intrauterine device among adolescent and young adult women in the United States from 2002 to 2010. J Adolesc Health. 2013;53:401–6.CrossRefPubMed
12.
go back to reference Daniels K, Daugherty J, Jones J, Mosher W. Current contraceptive use and variation by selected characteristics among women aged 15–44: United States, 2011–2013. Natl Health Stat Report. 2015;86:1–14. Daniels K, Daugherty J, Jones J, Mosher W. Current contraceptive use and variation by selected characteristics among women aged 15–44: United States, 2011–2013. Natl Health Stat Report. 2015;86:1–14.
Metadata
Title
Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion
Authors
Brandon Howard
ElizaBeth Grubb
Maureen J. Lage
Boxiong Tang
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Reproductive Health / Issue 1/2017
Electronic ISSN: 1742-4755
DOI
https://doi.org/10.1186/s12978-017-0334-1

Other articles of this Issue 1/2017

Reproductive Health 1/2017 Go to the issue